Table 3.
Correlation between IL1β, IL4, IL-6, IL-18, and IL-35 with all parameters in the moderate group.
| IL1β | IL4 | IL6 | IL18 | IL35 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| R | p | R | p | R | p | R | p | R | p | |
| ALT (U/L) | R | 0.502 | 0.227 * | 0.023 | 0.308 ** | 0.002 | 0.452 *** | 0.000 | 0.328 ** | 0.001 |
| AST(U/L) | 0.068 | 0.541 | 0.218 * | 0.029 | 0.318 ** | 0.001 | 0.460 *** | .000 | 0.332 ** | 0.001 |
| Albumin (g/dL) | 0.062 | 0.216 | −0.025 | 0.808 | −0.187 | 0.063 | −0.218 * | 0.029 | −0.140 | 0.164 |
| CRP(mg/dL) | −0.125 | 0.000 | 0.375 *** | 0.000 | 0.612 *** | 0.000 | 0.634 *** | 0.000 | 0.557 *** | 0.000 |
| IL-1β (pg/mL) | 0.504 *** | 0.429 *** | 0.000 | 0.530 *** | 0.000 | 0.445 *** | 0.000 | 0.610 *** | 0.000 | |
| IL-4 (pg/mL) | 1 | 0.000 | 1 | 0.513 *** | 0.000 | 0.495 *** | 0.000 | 0.592 *** | 0.000 | |
| IL-6 (pg/mL) | 0.429 *** | 0.000 | 0.513 *** | 0.000 | 1 | 0.793 *** | 0.000 | 0.654 *** | 0.000 | |
| IL-18 (pg/mL) | 0.530 *** | 0.000 | 0.495 *** | 0.000 | 0.793 *** | 0.000 | 1 | 0.606 *** | 0.000 | |
| IL-35 (pg/mL) | 0.445 *** | 0.000 | 0.592 *** | 0.000 | 0.654 *** | 0.000 | 0.606 *** | 0.000 | 1 | |
| PGE2(pg/mL) | 0.610 *** | 0.000 | 0.623 *** | 0.000 | 0.749 *** | 0.000 | 0.692 *** | 0.000 | 0.624 *** | 0.000 |
| TXA2 (pg/mL) | 0.464 *** | 0.000 | 0.681 *** | 0.000 | 0.700 *** | 0.000 | 0.718 *** | 0.000 | 0.734 *** | 0.000 |
| NF-κB p50 expression | 0.637 *** | 0.000 | 0.533 *** | 0.000 | 0.572 *** | 0.000 | 0.590 *** | 0.000 | 0.619 *** | 0.000 |
| NF-κB p65 expression | 0.481 *** | 0.000 | 0.463 *** | 0.000 | 0.549 *** | 0.000 | 0.611 *** | 0.000 | 0.671 *** | 0.000 |
| NRP-1 expression | 0.629 *** | 0.000 | 0.631 ** | 0.000 | 0.817 *** | 0.000 | 0.778 *** | 0.000 | 0.775 *** | 0.000 |
Significance for correlation was calculated at three levels: * p < 0.05, ** p < 0.01, and *** p < 0.001.